Partial characterization of the human serum transferrin epitope reactive with the monoclonal antibody TRC-2

Abstract

A murine monoclonal antibody (MAb) (TRC-2) specific for human serum transferrin (Tf-h) was developed. This antibody was depressive on cell growth in serum-free medium in the presence of limiting amounts of Tfh, but it did not inhibit the binding of Tf-h-alkaline phosphatase (AP) conjugate to the Tf-receptor (TfR) in a cellular enzyme-linked immunosorbent assay (CELISA) system. On the other hand, the immune complex Tf-h-TRC-2 was implicated to bind to the receptor in indirect CELISA. Moreover, the detectability of Tf-h-TfR on the cell surface via Tf-bound TRC-2 suggested that the antibody may inhibit the rapid internalization of this complex. To map the TRC-2-specific epitope, Tf-h was subjected to proteolytic degradation following sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. The treatment with trypsin gave rise to, among others, a fragment of about 42 kDa, which was reactive with TRC-2. Through sequence analysis by automated Edman degradation, the N-terminal sequence of the 42 kDa-tryptic fragment was aligned to the N-terminus of mature transferrin (VPDKTVR). The N-terminal sequence of an immunoreactive CNBr-fragment of about 13 kDa was, in turn, identical with the sequence (NQLRGKK) corresponding to the residues 110-116 on Tf-h.